TechLink Facebook Twitter Linkedin Search File Previous Next Arrow Right Materials Sensors Medical Biotechnology Millitary Tech Photonics Communications Electronics Energy Environmental Software Information and Technology Other Technologies Double Arrow Left

Air Force

Combined cholesterol and bilirubin tests as risk predictors for coronary artery disease

  • US Patent No. 6869802
  • Issued: March 22, 2005
  • Status: Expired
Medical & Biotechnology

A new method for predicting the risk of coronary artery disease (CAD) is disclosed. The method uses a ratio made up of the levels of an individuals LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C) and serum total bilirubin (bilirubin). The ratio, using a weighted value for bilirubin, is LDL-C/(HDL-C+bilirubin).

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us